Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Michael Horton

2106 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Global
  • News

White House’s Kirby Says No Evacuation Going On Of Embassy In Iraq

By Michael Horton
August 29, 12:57 PM
-Reuters

SPY

Read More
1 minute read
  • Legal
  • News

3M Appeals Court’s Refusal To Halt 230K Earplug Lawsuits

By Michael Horton
August 29, 12:51 PM
-Bloomberg

MMM

Read More
1 minute read
  • News

VBI Vaccines Says On August 26, 2022 Co. Delivered Written Notices To Jefferies To Terminate Each Of July 2022 Sales Agreement, September 2021 Sales Agreement, Effective Aug. 26, 2022

By Michael Horton
August 26, 4:47 PM
-SEC Filing

VBIV

Read More
1 minute read
  • News

Humanigen Says On August 24, 2022 Co. Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq

By Michael Horton
August 26, 4:37 PM
-Reuters

HGEN

Read More
2 minute read
  • News
  • Stock Split

MindMed Completes 1-for-15 Reverse Share Split

By Michael Horton
August 26, 4:33 PM
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today

MNMD

Read More
2 minute read
  • Management
  • News

Arlo Announces Changes in Executive Leadership, Kurt Binder Appointed As Chief Financial Officer

By Michael Horton
August 26, 4:32 PM
- Kurt Binder appointed as Chief Financial Officer - Brings deep experience in consumer, B2B, IoT and subscription services - Strengthens the leadership team focused on Arlo's Long-Range Plan Arlo Technologies,

ARLO

Read More
2 minute read
  • Management
  • News

CalAmp Announces CFO Transition, Kurt Binder To Step Down Effective Sept. 30, 2022

By Michael Horton
August 26, 4:16 PM
CalAmp (NASDAQ:CAMP), a connected intelligence company helping people and organizations improve operational performance with a data-driven solutions ecosystem, today announced that Kurt Binder will be stepping down from

CAMP

Read More
1 minute read
  • Trading Ideas

Top 15 Trending Stocks On WallStreetBets As Of Friday, August 26, 2022 (Via Swaggy Stocks)

By Michael Horton
August 26, 4:05 PM
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment   Bed Bath & Beyond (BBBY) Tesla (TSLA) Nvidia (NVDA) Apple (AAPL) GameStop (GME) Alibaba (BABA) ContextLogic

AAPL

Read More
1 minute read
  • News

Otonomo Announces Receipt OIf Nasdaq Non-Compliance Letter

By Michael Horton
August 26, 4:00 PM
Otonomo Technologies Ltd. (NASDAQ:OTMO) ("Otonomo" or the "Company"), the platform powering the mobility economy, today announced that it has received a written notification from the Listing

OTMO

Read More
1 minute read
  • News

Statera Biopharma Receives Anticipated Notice of Additional Filing Delinquency from Nasdaq

By Michael Horton
August 25, 5:31 PM
Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and

STAB

Posts pagination

Previous 1 … 168 169 170 … 211 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service